Tanaka H, Fujita N, Sugimoto R, Urawa N, Horiike S, Kobayashi Y, Iwasa M, Ma N, Kawanishi S, Watanabe S, Kaito M, Takei Y
Department of Gastroenterology and Hepatology, Division of Clinical Medicine and Biomedical Science, Institute of Medical Sciences, Mie University Graduate School of Medicine, Mie, Japan.
Br J Cancer. 2008 Feb 12;98(3):580-6. doi: 10.1038/sj.bjc.6604204. Epub 2008 Jan 29.
Although the oxidative stress frequently occurs in patients with chronic hepatitis C, its role in future hepatocellular carcinoma (HCC) development is unknown. Hepatic 8-hydroxydeoxyguanosine (8-OHdG) was quantified using liver biopsy samples from 118 naïve patients who underwent liver biopsy from 1995 to 2001. The predictability of 8-OHdG for future HCC development and its relations to epidemiologic, biochemical and histological baseline characteristics were evaluated. During the follow-up period (mean was 6.7+/-3.3 years), HCC was identified in 36 patients (30.5%). Univariate analysis revealed that 16 variables, including 8-OHdG counts (65.2+/-20.2 vs 40.0+/-23.5 cells per 10(5) microm2, P<0.0001), were significantly different between patients with and without HCC. Cox proportional hazard analysis showed that the hepatic 8-OHdG (P=0.0058) and fibrosis (P=0.0181) were independent predicting factors of HCC. Remarkably, 8-OHdG levels were positively correlated with body and hepatic iron storage markers (vs ferritin, P<0.0001 vs hepatic iron score, P<0.0001). This study showed that oxidative DNA damage is associated with increased risk for HCC and hepatic 8-OHdG levels are useful as markers to identify the extreme high-risk subgroup. The strong correlation between hepatic DNA damage and iron overload suggests that the iron content may be a strong mediator of oxidative stress and iron reduction may reduce HCC incidence in patients with chronic hepatitis C.
尽管氧化应激在慢性丙型肝炎患者中经常发生,但其在未来肝细胞癌(HCC)发生发展中的作用尚不清楚。使用1995年至2001年接受肝活检的118例初治患者的肝活检样本对肝脏8-羟基脱氧鸟苷(8-OHdG)进行定量。评估了8-OHdG对未来HCC发生发展的预测能力及其与流行病学、生化和组织学基线特征的关系。在随访期间(平均6.7±3.3年),36例患者(30.5%)被诊断为HCC。单因素分析显示,包括8-OHdG计数(每10(5)μm2分别为65.2±20.2和40.0±23.5个细胞,P<0.0001)在内的16个变量在有和无HCC的患者之间存在显著差异。Cox比例风险分析表明,肝脏8-OHdG(P=0.0058)和纤维化(P=0.0181)是HCC的独立预测因素。值得注意的是,8-OHdG水平与身体和肝脏铁储存标志物呈正相关(与铁蛋白相比,P<0.0001;与肝脏铁评分相比,P<0.0